Differential localization and high expression of SURVIVIN splice variants in human embryonic stem cells but not in differentiated cells implicate a role for SURVIVIN in pluripotency

Stem Cell Research

Volumn 12, Issue 2, 2014, Pages 539-549

  Mull, Amber N ^a   Klar, Amanda ^a   Navara, Christopher S ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; SHORT HAIRPIN RNA; SURVIVIN; TRANSCRIPTION FACTOR NANOG; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; ISOPROTEIN; POU5F1 PROTEIN, HUMAN; POU5F1 PROTEIN, MOUSE; SMALL INTERFERING RNA;

ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CHROMOSOME; CONTROLLED STUDY; CYTOPLASM; EMBRYONIC STEM CELL; EXON; GENE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTERPHASE; MITOSIS; MITOSIS SPINDLE; PLURIPOTENCY; PRIORITY JOURNAL; REDUCTION; SPLICE VARIANT; SURVIVIN 2ALPHA GENE; SURVIVIN 2B GENE; SURVIVIN 3B GENE; SURVIVIN EX3 GENE; SURVIVIN GENE; EMBRYO; FLOW CYTOMETRY; IMMUNOCYTOCHEMISTRY; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; SPLICING DEFECT; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; GENE EXPRESSION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; PROTEIN ISOFORMS; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84893426174     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.01.002     Document Type: Article

References (46)

1. Adida C., Crotty P.L., McGrath J., Berrebi D., Diebold J., Altieri D.C. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am. J. Pathol. 1998, 152(1):43-49.
2. Altieri D.C. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 2003, 3(1):46-54. ([pii]). 10.1038/nrc968 nrc968.
3. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 1997, 3(8):917-921.
4. Becker K.A., Ghule P.N., Therrien J.A., Lian J.B., Stein J.L., van Wijnen A.J. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J. Cell. Physiol. 2006, 209(3):883-893. 10.1002/jcp.20776.
5. Blum B., Bar-Nur O., Golan-Lev T., Benvenisty N. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat. Biotechnol. 2009, 27(3):281-287. (doi: nbt.1527 [pii] 1038/nbt.1527).
6. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122(6):947-956. (doi: S0092-8674(05)00825-1 [pii]). 10.1016/j.cell.2005.08.020.
7. Caldas H., Honsey L.E., Altura R.A. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies. Mol. Cancer 2005, 4(1):11. (doi: 1476-4598-4-11 [pii]). 10.1186/1476-4598-4-11.
8. Caldas H., Fangusaro J.R., Boue D.R., Holloway M.P., Altura R.A. Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis. Blood 2007, 109(4):1479-1489. (doi: blood-2006-02-003749 [pii]). 10.1182/blood-2006-02-003749.
9. Carmena M., Wheelock M., Funabiki H., Earnshaw W.C. The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis. Nat. Rev. Mol. Cell Biol. 2012, 13(12):789-803. (doi: nrm3474 [pii]). 10.1038/nrm3474.
10. Chantalat L., Skoufias D.A., Kleman J.P., Jung B., Dideberg O., Margolis R.L. Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions. Mol. Cell 2000, 6(1):183-189. (doi: S1097-2765(05)00020-1 [pii]).
11. Connell C.M., Wheatley S.P., McNeish I.A. Nuclear survivin abrogates multiple cell cycle checkpoints and enhances viral oncolysis. Cancer Res. 2008, 68(19):7923-7931. (doi: 68/19/7923 [pii]). 10.1158/0008-5472.CAN-08-0817.
12. Coumoul X., Li W., Wang R.H., Deng C. Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system. Nucleic Acids Res. 2004, 32(10):e85. (32/10/e85 [pii]). 10.1093/nar/gnh083.
13. Daheron L., Opitz S.L., Zaehres H., Lensch M.W., Andrews P.W., Itskovitz-Eldor J. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 2004, 22(5):770-778. (22/5/770 [pii]). 10.1634/stemcells.22-5-770.
14. Filion T.M., Qiao M., Ghule P.N., Mandeville M., van Wijnen A.J., Stein J.L. Survival responses of human embryonic stem cells to DNA damage. J. Cell. Physiol. 2009, 220(3):586-592. 10.1002/jcp.21735.
15. Fukuda S., Abe M., Onishi C., Taketani T., Purevsuren J., Yamaguchi S., Pelus L.M. Survivin selectively modulates genes deregulated in human leukemia stem cells. Journal of oncology 2011, 2011:946936.
16. Furuya M., Tsuji N., Kobayashi D., Watanabe N. Interaction between survivin and aurora-B kinase plays an important role in survivin-mediated up-regulation of human telomerase reverse transcriptase expression. Int. J. Oncol. 2009, 34(4):1061-1068.
17. Gheisari Y., Soleimani M., Zeinali S., Arefian E., Atashi A., Zarif M.N. Isolation of stem cells from adult rat kidneys. Biocell 2009, 33(1):33-38.
18. Guo Y., Mantel C., Hromas R.A., Broxmeyer H.E. Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3/survivin. Stem Cells 2008, 26(1):30-34. (doi: 2007-0401 [pii]). 10.1634/stemcells.2007-0401.
19. Humphrey R.K., Beattie G.M., Lopez A.D., Bucay N., King C.C., Firpo M.T. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem. Cells 2004, 22(4):522-530. (doi: 22/4/522 [pii]). 10.1634/stemcells.22-4-522.
20. Hwang N.S., Varghese S., Lee H.J., Zhang Z., Ye Z., Bae J. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(52):20641-20646. (doi: 0809680106 [pii]). 10.1073/pnas.0809680106.
21. Jeyaprakash A.A., Klein U.R., Lindner D., Ebert J., Nigg E.A., Conti E. Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. Cell 2007, 131(2):271-285. (doi: S0092-8674(07)01025-2 [pii]). 10.1016/j.cell.2007.07.045.
22. Jiang Y., de Bruin A., Caldas H., Fangusaro J., Hayes J., Conway E.M. Essential role for survivin in early brain development. J. Neurosci. 2005, 25:6962-6970. (doi: 25/30/6962 [pii] 0.1523/JNEUROSCI.1446-05.2005).
23. Kelly R.J., Lopez-Chavez A., Citrin D., Janik J.E., Morris J.C. Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin. Mol. Cancer 2011, 10:35. (doi: 1476-4598-10-35 [pii]). 10.1186/1476-4598-10-35.
24. Leung C.G., Xu Y., Mularski B., Liu H., Gurbuxani S., Crispino J.D. Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells. J. Exp. Med. 2007, 204(7):1603-1611. (doi: jem.20062395 [pii]). 10.1084/jem.20062395.
25. Li F. Role of survivin and its splice variants in tumorigenesis. Br. J. Cancer 2005, 92(2):212-216. (doi: 6602340 [pii]). 10.1038/sj.bjc.6602340.
26. Li C., Yan Y., Ji W., Bao L., Qian H., Chen L. OCT4 positively regulates survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma. PLoS One 2012, 7(11):e49693. (PONE-D-12-17776 [pii]). 10.1371/journal.pone.0049693.
27. Lin F., Lin P., Zhao D., Chen Y., Xiao L., Qin W. Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis. Cell Prolif. 2012, 45(3):207-216. 10.1111/j.1365-2184.2012.00812.x.
28. Ling X., Cheng Q., Black J.D., Li F. Forced expression of survivin-2B abrogates mitotic cells and induces mitochondria-dependent apoptosis by blockade of tubulin polymerization and modulation of Bcl-2, Bax, and survivin. J. Biol. Chem. 2007, 282(37):27204-27214. (doi: M705161200 [pii]). 10.1074/jbc.M705161200.
29. Mahotka C., Wenzel M., Springer E., Gabbert H.E., Gerharz C.D. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 1999, 59(24):6097-6102.
30. Mahotka C., Liebmann J., Wenzel M., Suschek C.V., Schmitt M., Gabbert H.E. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ. 2002, 9(12):1334-1342. 10.1038/sj.cdd.4401091.
31. Maimets T., Neganova I., Armstrong L., Lako M. Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene 2008, 27(40):5277-5287. (doi: onc2008166 [pii]). 10.1038/onc.2008.166.
32. Marconi A., Dallaglio K., Lotti R., Vaschieri C., Truzzi F., Fantini F. Survivin identifies keratinocyte stem cells and is downregulated by anti-beta1 integrin during anoikis. Stem Cells 2007, 25(1):149-155. (doi: 2006-0165 [pii]). 10.1634/stemcells.2006-0165.
33. Momcilovic O., Choi S., Varum S., Bakkenist C., Schatten G., Navara C. Ionizing radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and G(2) but not G(1) cell cycle arrest in pluripotent human embryonic stem cells. Stem Cells 2009, 27(8):1822-1835. 10.1002/stem.123.
34. Niwa H., Burdon T., Chambers I., Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998, 12(13):2048-2060.
35. Noton E.A., Colnaghi R., Tate S., Starck C., Carvalho A., Ko Ferrigno P. Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis. J. Biol. Chem. 2006, 281(2):1286-1295. (doi: M508773200 [pii]). 10.1074/jbc.M508773200.
36. Rodriguez J.A., Span S.W., Ferreira C.G., Kruyt F.A., Giaccone G. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Exp. Cell Res. 2002, 275(1):44-53. (S0014482702954923 [pii]). 10.1006/excr.2002.5492.
37. Salz W., Eisenberg D., Plescia J., Garlick D.S., Weiss R.M., Wu X.R. A survivin gene signature predicts aggressive tumor behavior. Cancer Res. 2005, 65((9):3531-3534. (doi: 65/9/3531 [pii]). 10.1158/0008-5472.CAN-04-4284.
38. Song Z., Wu M. Identification of a novel nucleolar localization signal and a degradation signal in Survivin-deltaEx3: a potential link between nucleolus and protein degradation. Oncogene 2005, 24(16):2723-2734. (doi: 1208097 [pii] 10.1038/sj.onc.1208097).
39. Stauber R.H., Rabenhorst U., Rekik A., Engels K., Bier C., Knauer S.K. Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal. Traffic 2006, 7((11):1461-1472. (doi: TRA486 [pii]). 10.1111/j.1600-0854.2006.00486.x.
40. Stewart R., Yang C., Anyfantis G., Przyborski S., Hole N., Strachan T. Silencing of the expression of pluripotent driven-reporter genes stably transfected into human pluripotent cells. Regen. Med. 2008, 3(4):505-522. 10.2217/17460751.3.4.505.
41. Suzuki a, Hayashida M., Ito T., Kawano H., Nakano T., Miura M., Shiraki K. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene 2000, 19(29):3225-3234.
42. Uren A.G., Wong L., Pakusch M., Fowler K.J., Burrows F.J., Vaux D.L. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr. Biol. 2000, 10(21):1319-1328. (doi: S0960-9822(00)00769-7 [pii]).
43. Verdecia M.A., Huang H., Dutil E., Kaiser D.A., Hunter T., Noel J.P. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat. Struct. Biol. 2000, 7(7):602-608. 10.1038/76838.
44. Wang H., Holloway M.P., Ma L., Cooper Z.A., Riolo M., Samkari A. Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity. J. Biol. Chem 2010, (doi: M110.152777 [pii]). 10.1074/jbc.M110.152777.
45. Zhang T., Otevrel T., Gao Z., Ehrlich S.M., Fields J.Z., Boman B.M. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 2001, 61(24):8664-8667.
46. Zwerts F., Lupu F., De Vriese A., Pollefeyt S., Moons L., Altura R.A. Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure. Blood 2007, 109(11):4742-4752. (doi: blood-2006-06-028068 [pii] 1182/blood-2006-06-028068).